Q4 2022 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.
Good afternoon, and thank you for joining the INOVIO 2022 Fourth Quarter and Full Year Financial Results Conference Call. Joining me on today's call are Dr. Jacqui Shea, President and CEO; Dr. Michael Sumner, Chief Medical Officer; and Mr. Peter Kies, Chief Financial Officer. We also have other members of INOVIO's leadership here with us today who will be part of our Q&A session.
Today's call will review our corporate and financial information for the quarter and year ended December 31, 2022, as well as provide an update on our efforts to develop our DNA medicines platform. Following prepared remarks, we will conduct a question-and-answer segment.
During the call, we will be making forward-looking statements regarding future events and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |